Literature DB >> 1900481

Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate.

W Schoolcraft1, E Sinton, T Schlenker, D Huynh, F Hamilton, D R Meldrum.   

Abstract

The relationship of the circulating level of progesterone (P) on the day of human chorionic gonadotropin (hCG) injection to occurrence of clinical pregnancy was examined in 133 leuprolide acetate human menopausal gonadotropin (hMG) in vitro fertilization cycles in women having at least three embryos transferred. Progesterone concentrations greater than 0.5 ng/mL were associated with a significantly lower rate of pregnancy (12/59, 20%) compared with less than 0.5 ng/mL (40/74, 54%, P less than 0.005). The higher P cycles were associated with greater patient age and hMG dose, although these relationships appeared to be indirect. Luteinizing hormone (LH) concentrations remained suppressed. Ovarian stimulation may cause excessive luteinization and an adverse cycle outcome even in the presence of low LH levels. Prospective use of P levels may be helpful to determine optimal hCG timing.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900481

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  45 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Progesterone rise on the day of HCG administration (premature luteinization) in IVF: an overdue update.

Authors:  Aboubakr M Elnashar
Journal:  J Assist Reprod Genet       Date:  2010-02-23       Impact factor: 3.412

3.  17-hydroxyprogesterone levels are not helpful in the prediction of HCG timing in in vitro fertilization cycles.

Authors:  K E Smith; G Garzo; F Hamilton; D R Meldrum
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

4.  Elevated progesterone and its impact on birth weight after fresh embryo transfers.

Authors:  Yetunde Ibrahim; Miriam J Haviland; Michele R Hacker; Alan S Penzias; Kim L Thornton; Denny Sakkas
Journal:  J Assist Reprod Genet       Date:  2017-04-17       Impact factor: 3.412

Review 5.  Adverse effect of prematurely elevated progesterone in in vitro fertilization cycles: a literature review.

Authors:  Michael B Evans; Mae W Healy; Alan H DeCherney; Micah J Hill
Journal:  Biol Reprod       Date:  2018-07-01       Impact factor: 4.285

6.  The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a "long protocol" of gonadotropin releasing hormone analogue and human menopausal gonadotropins.

Authors:  A Shulman; Y Ghetler; Y Beyth; I Ben-Nun
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

7.  A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients.

Authors:  M Dirnfeld; S Goldman; Y Gonen; M Koifman; A Lissak; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-02       Impact factor: 3.412

8.  Elevated serum progesterone values at the time of ovulation induction in luteal leuprolide acetate-down-regulated GIFT cycles are associated with decreased clinical pregnancy rates.

Authors:  G W Randall; P A Gantt; D Gantt; M J Kirk; N Romines
Journal:  J Assist Reprod Genet       Date:  1996-07       Impact factor: 3.412

9.  Does subtle progesterone rise on the day of HCG affect pregnancy rate in long agonist ICSI cycles?

Authors:  Hisham Ali Saleh; Mervat Sheikh El-Arab Omran; Mohamed Draz
Journal:  J Assist Reprod Genet       Date:  2009-05-21       Impact factor: 3.412

10.  The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome.

Authors:  M J Levy; D B Smotrich; E A Widra; A W Sagoskin; D L Murray; J L Hall
Journal:  J Assist Reprod Genet       Date:  1995-03       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.